Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Stryker Continues Strong Sales Growth; Raises Full-Year Guidance - Orthopedic Design & Technology
Financial/Business, OEM News

Stryker Continues Strong Sales Growth; Raises Full-Year Guidance

The company posted Q1 earnings of $788 million on $5.2 billion of revenue, rising 33.1% in the quarter.

Stryker has reported its Q1 2024 earnings (ending March 31), and looks to be continuing its strong sales growth.
 
The Kalamazoo, Mich.-based company posted $5.2 billion in net sales in Q1, increasing 9.7% (10.2% in constant currency). Organic net sales rose 10% in the quarter—9.3% from increased unit volume and 0.7% from higher prices.
 
The company’s MedSurg and Neurotechnology businesses posted $3 billion in the quarter, growing 11.5% (12% in constant currency). Organic net sales in these portfolios increased 11.6% in the quarter. Orthopaedics and Spine reported $2.2 billion in proceeds, rising 7.5% in the quarter (8% in constant currency). Organic net sales here grew 8%.
 
The company reported Q1 net earnings of $788 million—$2.05 per share—on the $5.2 billion of revenue, rising 33.1% in the quarter. Adjusted net earnings per diluted share of $2.50 increased 16.8% in the quarter as well.
 
Stryker upped its 2024 full-year guidance as a result. The company now expects organic net sales growth to be in the 8.5%-9.5% range, with adjusted net earnings per diluted share to be in the range of $11.85-$12.05.
 
“Our momentum from 2023 continued into the first quarter as we delivered 10% organic sales growth,” said Kevin A. Lobo, Stryker’s chair and CEO. “Our teams are executing well and I am confident in our ability to grow sales at the high end of MedTech and drive strong adjusted earnings growth in 2024.”

Stryker’s Q1 2024 Highlights

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters